SecBot SecBot
8-K ·Filed Sep 24, 2026

PRCT

PROCEPT BioRobotics Corp
NEUTRAL
Impact 3/10
Horizonmonths Processed1mo ago SEC0001588978-26-000034
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Actionable Insight • Neutral

The maturity extension provides near-term liquidity relief but does not alter the company's debt capacity or cost of capital. Monitor upcoming quarterly filings for cash burn rate and whether the company will need to refinance or repay the term loan by October 2028.

DirectionNeutral
Confidencehigh
Horizonmonths
Latest settled — T+20d
PRCT ▲ +16.05% at T+20d
NEUTRAL call +16.05% · α vs SPY +17.52% · entry $17.20 → $19.96
Next anchor: T+60d in 7w
Entry = T+0 close
Sep 24, 2026
via day close
T+1d
+0.29%
call +0.29% · α +1.03%
$17.25
settled 5w ago
T+5d
-0.23%
call -0.23% · α -0.01%
$17.16
settled 26d ago
T+20d
+16.05%
call +16.05% · α +17.52%
$19.96
settled 5d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

PROCEPT BioRobotics entered into a Third Amendment to its Loan and Security Agreement with CIBC, extending the Term Loan Maturity Date by 12 months from October 1, 2027 to October 1, 2028. The amendment involved a $26,000 non-refundable fee, and the company represented that no Event of Default has occurred. This is a routine debt maturity extension with no changes to financial covenants or loan size.

Key Financial Metrics

Deal Type
credit_facility

Key Facts

  • Term Loan Maturity Date extended by 12 months, from October 1, 2027 to October 1, 2028
  • Non-refundable extension amendment fee of $26,000 paid to CIBC
  • No Event of Default has occurred and is continuing per company representation
  • All other terms, covenants, and conditions of the Loan Agreement remain unchanged

Financial Impact

Minimal — $26,000 fee paid for a 12-month maturity extension; no change to loan principal, interest rate, or covenants

debt_maturity

Risk Factors

  • Extension does not reduce outstanding principal — refinancing risk remains at the new maturity date
  • No new capital raised; the company's cash runway and operating performance remain key credit factors

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001588978-26-000034
Exhibit: exhibit101proceptbioroboti.htm0001588978-26-000034
Document: 0001588978-26-000034-index-headers.html0001588978-26-000034
Document: 0001588978-26-000034-index.html0001588978-26-000034
Document: 0001588978-26-000034.txt0001588978-26-000034
13 reports for PRCT
Performance horizon
100% Hit rate @ T+60 4 of 4 directional calls Went positive at some point 5 of 5 best @ T+60▲ +22.73%Feb 26, 2026
Filters
Rows
Reports for PRCT — sortable, filterable
TypeNow
Oct 2, 2026
25d ago
8-K
NEUTRAL ★ 2/10
$17.82awaiting T+60—$19.80 (+11.11%)
Sep 24, 2026
4w ago
8-K
NEUTRAL ★ 3/10
$17.20awaiting T+60—$19.80 (+15.12%)
Aug 10, 2026
11w ago
Insider Buy
BULLISH ★ 5/10
$21.71awaiting T+60—$19.80 (−8.80%)
Jun 11, 2026
19w ago
Institutional Cluster
MIXED ★ 4/10
$27.69 $21.35▼ −22.90%▼ −26.72%$19.80 (−28.49%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$27.69 $21.35▼ −22.90%▼ −26.72%$19.80 (−28.49%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$27.69 $21.35▼ −22.90%▼ −26.72%$19.80 (−28.49%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$27.69 $21.35▼ −22.90%▼ −26.72%$19.80 (−28.49%)
Mar 10, 2026
33w ago
Insider Cluster
NEUTRAL ★ 2/10
$24.17 $26.33▲ +8.94%▼ −2.75%$19.80 (−18.08%)
Mar 6, 2026
33w ago
8-K
NEUTRAL ★ 3/10
$24.22 $27.86▲ +15.03%▲ +2.25%$19.80 (−18.25%)
Mar 6, 2026
33w ago
Insider Cluster
BULLISH ★ 7/10
$24.22 $27.86▲ +15.03%▲ +2.25%$19.80 (−18.25%)
Showing 10 of 13

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 24, 2026